Publication

Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency

Comeau, Anne Marie
Hale, Jaime E
Pai, Sung-Yun
Bonilla, Francisco A.
Notarangelo, Luigi D.
Pasternack, Mark S.
Meissner, H. Cody
Cooper, Ellen Rae
DeMaria, Alfred
Sahai, Inderneel
... show 1 more
Embargo Expiration Date
Abstract

Severe combined immunodeficiency (SCID) is a Primary Immune Deficiency that is under consideration for population-based newborn screening (NBS) by many NBS programs, and has recently been recommended for inclusion in the US uniform panel of newborn screening conditions. A marker of SCID, the T cell receptor excision circle (TREC), is detectable in the newborn dried blood spot using a unique molecular assay as a primary screen. The New England Newborn Screening Program developed and validated a multiplex TREC assay in which both the TREC analyte and an internal control are acquired from a single punch and run in the same reaction. Massachusetts then implemented a statewide pilot SCID NBS program. The authors describe the rationale for a pilot SCID NBS program, a comprehensive strategy for successful implementation, the screening test algorithm, the screening follow-up algorithm and preliminary experience based on statewide screening in the first year. The Massachusetts experience demonstrates that SCID NBS is a program that can be implemented on a population basis with reasonable rates of false positives.

Source

J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S273-81. Epub 2010 May 20. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1007/s10545-010-9103-9
PubMed ID
20490925
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License